Trial intelligence / Profile preview

Smecta + ORS for acute watery diarrhoea in children

NCT00352716Phase 3Completed

Sponsor
Ipsen
Start
Jun 2006
Primary completion
Feb 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in acute watery diarrhea comparing Smecta + ORS with Placebo + ORS (2 arms). Primary endpoint: Cumulative faecal output per body weight at 72 hours. Started Jun 2006; status: completed.

02

Drugs

diosmectite
03

Conditions

acute watery diarrhea

Beyond the preview

Go deeper on NCT00352716.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00352716.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call